Raphael Pharmaceutical, Inc. is an emerging pharmaceutical research and clinical development company with limited operation history. It has focused on developing its rheumatoid arthritis product candidate. The company was founded on May 17, 2007 and is headquartered in Tel Aviv, Israel.